Replicel

[WillhasWill]

If Replicel bring to market a new and standardised treatment for hair loss with non significant side affects and which produces more hair growth than the best treatments available today then it will not be a good business decision to charge 20k or high figures like this.

As a drug the over heads will be low. It won't be like a transplant, which requires a team for 10 hours or so. It will be best to sell cheaper and therefore hit the mass market and they will make more money.

Over charging and pricing people out of the treatment will probably mean they will make less.

If this treatment is a success it should be surprisingly affordable.